Gut microflora in the pathogenesis of the complications of cirrhosis
- PMID: 15123075
- DOI: 10.1016/j.bpg.2003.10.005
Gut microflora in the pathogenesis of the complications of cirrhosis
Abstract
The gut flora plays an important role in the pathogenesis of the complications of cirrhosis. Cirrhotic patients are prone to develop bacterial infections, mainly the 'spontaneous' infection of ascites or spontaneous bacterial peritonitis. Other complications of cirrhosis, such as variceal haemorrhage and ascites, occur mostly or solely as a consequence of portal hypertension. Portal pressure increases initially as a consequence of an increased intrahepatic resistance but, once collaterals have formed, high portal pressure is maintained by an increased splanchnic blood inflow secondary to vasodilatation. Splanchnic vasodilatation is the initiating event in the hyperdynamic circulatory state that aggravates the complications of cirrhosis. The gut flora plays a role in both the development of infections and in the hyperdynamic circulatory state of cirrhosis and, although less prominently, it also plays a role in the pathogenesis of hepatic encephalopathy. This chapter presents evidence regarding gut flora and its modification in the pathogenesis and management of these complications of cirrhosis.
Similar articles
-
[The role of intestinal microflora in the development of complications of hepatic cirrhosis-associated portal hypertension].Klin Med (Mosk). 2007;85(8):15-9. Klin Med (Mosk). 2007. PMID: 17926483 Review. Russian.
-
Portal hypertension.Curr Opin Gastroenterol. 2006 May;22(3):254-62. doi: 10.1097/01.mog.0000218962.93806.9a. Curr Opin Gastroenterol. 2006. PMID: 16550040 Review.
-
Gut microbiota-related complications in cirrhosis.World J Gastroenterol. 2014 Nov 14;20(42):15624-31. doi: 10.3748/wjg.v20.i42.15624. World J Gastroenterol. 2014. PMID: 25400446 Free PMC article. Review.
-
[Antibiotics can ameliorate circulatory complications of liver cirrhosis].Ugeskr Laeger. 2011 Aug 29;173(35):2127-30. Ugeskr Laeger. 2011. PMID: 21884664 Danish.
-
[Current problems in the prevention and treatment of infections in patients with cirrhosis].Gastroenterol Hepatol. 2010 Dec;33(10):729-40. doi: 10.1016/j.gastrohep.2010.02.004. Epub 2010 May 4. Gastroenterol Hepatol. 2010. PMID: 20444525 Review. Spanish.
Cited by
-
Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis.Dig Dis Sci. 2016 Dec;61(12):3621-3626. doi: 10.1007/s10620-016-4313-0. Epub 2016 Sep 21. Dig Dis Sci. 2016. PMID: 27655104
-
Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis.Front Physiol. 2018 May 1;9:470. doi: 10.3389/fphys.2018.00470. eCollection 2018. Front Physiol. 2018. PMID: 29780327 Free PMC article.
-
Metabolic Dysregulation and Metabolite Imbalances in Acute-on-chronic Liver Failure: Impact on Immune Status.J Clin Transl Hepatol. 2024 Oct 28;12(10):865-877. doi: 10.14218/JCTH.2024.00203. Epub 2024 Sep 19. J Clin Transl Hepatol. 2024. PMID: 39440217 Free PMC article. Review.
-
Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis.Biomed Res Int. 2020 Jul 6;2020:3743962. doi: 10.1155/2020/3743962. eCollection 2020. Biomed Res Int. 2020. PMID: 32724800 Free PMC article. Review.
-
Gut flora and bacterial translocation in chronic liver disease.World J Gastroenterol. 2006 Mar 14;12(10):1493-502. doi: 10.3748/wjg.v12.i10.1493. World J Gastroenterol. 2006. PMID: 16570339 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical